233 related articles for article (PubMed ID: 35417906)
1. Non-Atopic Chronic Nodular Prurigo (Prurigo Nodularis Hyde): A Systematic Review of Best-Evidenced Treatment Options.
Frølunde AS; Wiis MAK; Ben Abdallah H; Elsgaard S; Danielsen AK; Deleuran M; Vestergaard C
Dermatology; 2022; 238(5):950-960. PubMed ID: 35417906
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis.
Alkon N; Assen FP; Arnoldner T; Bauer WM; Medjimorec MA; Shaw LE; Rindler K; Holzer G; Weber P; Weninger W; Freystätter C; Chennareddy S; Kinaciyan T; Farlik M; Jonak C; Griss J; Bangert C; Brunner PM
J Allergy Clin Immunol; 2023 Aug; 152(2):420-435. PubMed ID: 37210042
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of biologics in prurigo nodularis.
Müller S; Bieber T; Ständer S
Expert Opin Biol Ther; 2022 Jan; 22(1):47-58. PubMed ID: 34289753
[TBL] [Abstract][Full Text] [Related]
4. Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments.
Müller S; Zeidler C; Ständer S
Am J Clin Dermatol; 2024 Jan; 25(1):15-33. PubMed ID: 37717255
[TBL] [Abstract][Full Text] [Related]
5. Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment.
Wong LS; Yen YT
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293248
[TBL] [Abstract][Full Text] [Related]
6. Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.
Serra-Baldrich E; Santamaría-Babí LF; Francisco Silvestre J
Actas Dermosifiliogr; 2022; 113(7):674-684. PubMed ID: 35842249
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and treatment algorithm for chronic nodular prurigo.
Ständer HF; Elmariah S; Zeidler C; Spellman M; Ständer S
J Am Acad Dermatol; 2020 Feb; 82(2):460-468. PubMed ID: 31310842
[TBL] [Abstract][Full Text] [Related]
8. Chronic Nodular Prurigo: A Retrospective Study of 74 Cases.
Espiñeira Sicre J; Docampo Simón A; Silvestre Salvador JF
Actas Dermosifiliogr; 2022 Oct; 113(9):866-873. PubMed ID: 35659612
[TBL] [Abstract][Full Text] [Related]
9. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
[TBL] [Abstract][Full Text] [Related]
10. Systemic Medication for the Treatment of Prurigo Nodularis-A Systematic Review.
McCampbell LE; Zaino ML; Ranpariya M; Patel T; Feldman SR
J Cutan Med Surg; 2023 Nov; 27(6):641-645. PubMed ID: 37987710
[TBL] [Abstract][Full Text] [Related]
11. Phototherapy for Prurigo Nodularis: Our Experience and a Review of the Literature.
Arrieta A; Jaka A; Del Alcázar E; Blanco M; Carrascosa JM
Actas Dermosifiliogr (Engl Ed); 2021 Apr; 112(4):339-344. PubMed ID: 33221272
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial.
Siepmann D; Lotts T; Blome C; Braeutigam M; Phan NQ; Butterfass-Bahloul T; Augustin M; Luger TA; Ständer S
Dermatology; 2013; 227(4):353-60. PubMed ID: 24281309
[TBL] [Abstract][Full Text] [Related]
13. Prurigo nodularis: a review.
Lee MR; Shumack S
Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of evidence-based treatments for prurigo nodularis.
Qureshi AA; Abate LE; Yosipovitch G; Friedman AJ
J Am Acad Dermatol; 2019 Mar; 80(3):756-764. PubMed ID: 30261199
[TBL] [Abstract][Full Text] [Related]
15. Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo.
Chiricozzi A; Maurelli M; Gori N; Argenziano G; De Simone C; Calabrese G; Girolomoni G; Peris K
J Am Acad Dermatol; 2020 Jul; 83(1):39-45. PubMed ID: 32229281
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide for the treatment of chronic refractory pruritus.
Sharma D; Kwatra SG
J Am Acad Dermatol; 2016 Feb; 74(2):363-9. PubMed ID: 26577510
[TBL] [Abstract][Full Text] [Related]
17. Prurigo nodularis of Hyde treated with low-dose thalidomide.
Orlando A; Renna S; Cottone M
Eur Rev Med Pharmacol Sci; 2009; 13(2):141-5. PubMed ID: 19499850
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide for the treatment of chronic refractory prurigo nodularis.
Aguh C; Kwatra SG; He A; Okoye GA
Dermatol Online J; 2018 Mar; 24(3):. PubMed ID: 29634881
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
Husein-ElAhmed H; Steinhoff M
J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic, Epigenomic, and Neuroanatomic Signatures Differ in Chronic Prurigo, Atopic Dermatitis, and Brachioradial Pruritus.
Agelopoulos K; Renkhold L; Wiegmann H; Dugas M; Süer A; Zeidler C; Schmelz M; Pereira MP; Ständer S
J Invest Dermatol; 2023 Feb; 143(2):264-272.e3. PubMed ID: 36075451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
